At what enterprise value was THE BRIDGE BIO acquired in 2026?

You can find the full valuation details of THE BRIDGE BIO on mynth capital. By registering for free, you get access to complete and exact transaction details including enterprise value, revenue, and EBITDA. Additionally, our database shows that the AgriFood industry currently tracks an average EBITDA multiple of 10.6x, providing a valuable benchmark for this transaction.

What was the EV/EBITDA of THE BRIDGE BIO when it was acquired by AMBIENTA?

The exact EV/EBITDA multiple for THE BRIDGE BIO is available on mynth capital. For comparison, the AgriFood sector currently shows an average EBITDA multiple of 10.6x. Join our community for free to access full valuation data and industry trends.

When was THE BRIDGE BIO acquired by AMBIENTA?

THE BRIDGE BIO was acquired by AMBIENTA in 2026.

What was the revenue of THE BRIDGE BIO at the time of the deal?

The revenue of THE BRIDGE BIO at the time of the deal is estimated to be in the range of 25M - 50M EUR. Register for free to access the full transaction report and exact valuation multiples.

What was the EBITDA of THE BRIDGE BIO during the acquisition?

THE BRIDGE BIO's EBITDA is estimated to be in the range of 0M - 5M EUR. Join our community for free to access complete and exact deal data.

What is Enterprise Value (EV)?

Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

What is the EV/EBITDA multiple and why is it used?

The EV/EBITDA multiple is a financial ratio that compares a company's Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). It is widely used in M&A and valuation because it allows for comparisons between companies with different capital structures and provides a clear view of operational profitability.

How is the data for the THE BRIDGE BIO acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the THE BRIDGE BIO deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://ambientasgr.com/wp-content/uploads/2026/03/The-Bridge_PR_FR-vF.pdf

← DATABASE

Home Database AgriFoodTHE BRIDGE BIO

04/2026

THE BRIDGE BIO

Acquired by

AMBIENTA

ITALY Food Processing / Beverages / Soft Drinks REV 25M - 50M EUR

THE BRIDGE BIO acquired by AMBIENTA

ITALY Food Processing / Beverages / Soft Drinks REV 25M - 50M EUR

Context

Ambienta SGR, through its Small Cap fund, has acquired a majority stake in The Bridge from the founding Negro Marcigaglia family. The founders have committed to reinvesting alongside the private equity firm and will continue to play a key leadership role in the company's development. The strategic rationale for the acquisition is to capitalize on the robust growth of the plant-based food sector, driven by consumer shifts toward sustainable and healthier diets. Ambienta intends to leverage its international network and sustainability expertise to accelerate The Bridge’s expansion, strengthen its organizational structure, and further invest in product innovation. This transaction marks the second investment for Ambienta’s Small Cap strategy, following the recent acquisition of Pieco.

THE BRIDGE BIO, which reported an EBITDA margin of LOGIN in 2025, is valued in this transaction at an EV/EBITDA multiple of LOGIN, a level to compare with the average currently observed in the AgriFood sector (10.6x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in AgriFood market trends

Target

The Bridge (Bio S.r.l.), founded in 1994, is a pioneering specialist in the development and production of 100% organic plant-based beverages, yogurts, and desserts. The organization operates a fully internalized and integrated business model, covering the entire manufacturing process from raw material extraction to UHT treatment and final packaging. This "farm-to-shelf" integration allows for high flexibility and strict quality control, focusing on "short labels" and product innovation. With a strong international vocation, the entity generates approximately 80% of its turnover outside of Italy, distributing through its own brand and as a high-end private label partner. The group is positioned at the intersection of the healthy-aging and environmental sustainability trends, serving the rapidly growing 4.3 billion EUR European plant-based dairy alternative market.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2025

2024

Other operations with THE BRIDGE BIO

REFERENCES

Revenue range: 25M - 50M EUR

EBITDA range: 0M - 5M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of THE BRIDGE BIO by AMBIENTA are reserved for mynth community members. Register for free to unlock full data.

Authors: mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).

Press release: view release

Target: the bridge bio

Acquirer: ambienta